FI882041A - Menetelmä elävän herpesvirusrokotteen lyofilisoimiseksi - Google Patents

Menetelmä elävän herpesvirusrokotteen lyofilisoimiseksi Download PDF

Info

Publication number
FI882041A
FI882041A FI882041A FI882041A FI882041A FI 882041 A FI882041 A FI 882041A FI 882041 A FI882041 A FI 882041A FI 882041 A FI882041 A FI 882041A FI 882041 A FI882041 A FI 882041A
Authority
FI
Finland
Prior art keywords
lyophilizing
herpesvirus vaccine
live herpesvirus
live
vaccine
Prior art date
Application number
FI882041A
Other languages
English (en)
Swedish (sv)
Other versions
FI94093C (fi
FI94093B (fi
FI882041A0 (fi
Inventor
William J Mcaleer
Henry Z Markus
Robert Z Maigetter
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI882041A0 publication Critical patent/FI882041A0/fi
Publication of FI882041A publication Critical patent/FI882041A/fi
Application granted granted Critical
Publication of FI94093B publication Critical patent/FI94093B/fi
Publication of FI94093C publication Critical patent/FI94093C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0015—Combination vaccines based on measles-mumps-rubella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI882041A 1987-05-04 1988-05-02 Menetelmä elävän herpesvirusrokotteen lyofilisoimiseksi FI94093C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4594087A 1987-05-04 1987-05-04
US4594087 1987-05-04

Publications (4)

Publication Number Publication Date
FI882041A0 FI882041A0 (fi) 1988-05-02
FI882041A true FI882041A (fi) 1988-11-05
FI94093B FI94093B (fi) 1995-04-13
FI94093C FI94093C (fi) 1995-07-25

Family

ID=21940663

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882041A FI94093C (fi) 1987-05-04 1988-05-02 Menetelmä elävän herpesvirusrokotteen lyofilisoimiseksi

Country Status (16)

Country Link
EP (1) EP0290197B1 (fi)
JP (1) JP2643982B2 (fi)
KR (1) KR960016581B1 (fi)
AT (1) ATE95427T1 (fi)
AU (1) AU622110B2 (fi)
CA (1) CA1324956C (fi)
DE (1) DE3884663T2 (fi)
DK (1) DK238688A (fi)
FI (1) FI94093C (fi)
HK (1) HK5997A (fi)
IE (1) IE61575B1 (fi)
IL (1) IL86180A (fi)
NO (1) NO176163C (fi)
NZ (1) NZ224419A (fi)
PT (1) PT87388B (fi)
ZA (1) ZA883133B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2000034A6 (es) * 1985-11-26 1987-10-01 Schweiz Serum & Impfinst Procedimiento para la preparacion de una vacuna viva contra paperas
IL120202A (en) 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
GB9808922D0 (en) 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
BRPI0014142B8 (pt) 1999-08-24 2021-05-25 Abic Biological Laboratories Ltd composição de vacina comprimida estável, e, pacote para vacinação
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
AR063606A1 (es) 2006-11-07 2009-02-04 Acambis Inc Estabilizacion de vacunas mediante liofilizacion
AU2012245198B2 (en) * 2011-04-21 2017-07-13 Trustees Of Tufts College Compositions and methods for stabilization of active agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (fi) * 1974-03-12 1978-11-01
GB1481650A (en) * 1975-05-06 1977-08-03 Merck & Co Inc Chemical processes and products
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
DK331087A (da) * 1986-06-30 1987-12-31 Smith Kline Rit Stabilisator for levende vaccine

Also Published As

Publication number Publication date
FI94093C (fi) 1995-07-25
EP0290197B1 (en) 1993-10-06
KR880013575A (ko) 1988-12-21
DK238688A (da) 1988-11-05
ATE95427T1 (de) 1993-10-15
ZA883133B (en) 1988-11-08
DK238688D0 (da) 1988-05-03
JPS646220A (en) 1989-01-10
AU1552788A (en) 1988-11-10
NO176163B (no) 1994-11-07
DE3884663D1 (de) 1993-11-11
EP0290197A2 (en) 1988-11-09
NO881931D0 (no) 1988-05-03
CA1324956C (en) 1993-12-07
FI94093B (fi) 1995-04-13
AU622110B2 (en) 1992-04-02
HK5997A (en) 1997-01-17
NO881931L (no) 1988-11-07
JP2643982B2 (ja) 1997-08-25
KR960016581B1 (ko) 1996-12-16
NO176163C (no) 1995-02-15
PT87388A (pt) 1989-05-31
IL86180A0 (en) 1988-11-15
DE3884663T2 (de) 1994-04-07
IL86180A (en) 1992-08-18
PT87388B (pt) 1992-08-31
NZ224419A (en) 1991-03-26
IE881248L (en) 1988-11-04
FI882041A0 (fi) 1988-05-02
EP0290197A3 (en) 1989-10-18
IE61575B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
FR2620459B1 (fr) Virus recombinant de la vaccine
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DE3587991T2 (de) Rekombinanter herpes simplex gb-gd impfstoff.
FI882041A0 (fi) Menetelmä elävän herpesvirusrokotteen lyofilisoimiseksi
GB2264949B (en) Measles virus recombinant poxvirus vaccine
DK331087D0 (da) Stabilisator for levende vaccine
FR2685065B1 (fr) Procede de regulation de lyophilisation.
KR890700388A (ko) 대기로부터 휘발성 화합물을 회수하는 방법
BG45570A1 (en) Means for virus desease cure
DE3681229D1 (de) Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
ATE165620T1 (de) Impfstoffe auf basis geänderter boviner herpesviren typ 1
GB9213882D0 (en) Live modified equine herpesvirus-4 vaccine
FR2602681B1 (fr) Procede de preparation d'un vaccin recombinant contre l'hepatite b
ZA919198B (en) Measles virus recombinant poxvirus vaccine
ATA245087A (de) Foerdergeblaese fuer erntegut
ZA883365B (en) Newcastle disease virus vaccine and method for the application thereof
KR890006532U (ko) 에어 임펙트 렌치의 스타트 보울트 소켓

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERCK & CO., INC.

MA Patent expired